世界の新型コロナウイルス感染症用抗体&血清検査器市場予測 2022年-2028年

【英語タイトル】Global COVID-19 Antibody and Serology Tests Market Growth 2022-2028

LP Informationが出版した調査資料(LPI22SM17186)・商品コード:LPI22SM17186
・発行会社(調査会社):LP Information
・発行日:2022年9月
・ページ数:128
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

世界経済が回復するにつれて、2021年の新型コロナウイルス感染症用抗体&血清検査器の成長は前年から大幅に変化します。LPインフォメーション社の最新の調査によると、世界の新型コロナウイルス感染症用抗体&血清検査器市場規模は、2021年のxxxドルから2022年にはxxxドルに達し、2021年~2022年間にxxx%の変化が予想されます。2028年には世界の新型コロナウイルス感染症用抗体&血清検査器市場規模がxxxドルまで成長し、分析期間中にxxx%のCAGRを記録すると予想されます。
アメリカの新型コロナウイルス感染症用抗体&血清検査器市場は2021年にxxxドルの市場規模が見込まれ、分析期間中は約xxx%のCAGRで成長すると予測されます。中国は世界の新型コロナウイルス感染症用抗体&血清検査器市場のxxx%のシェアを占め、2028年までにxxxドルに達すると展望されます。ヨーロッパの新型コロナウイルス感染症用抗体&血清検査器の状況については、ドイツが2028年までにxxxドルに達し、分析期間にわたってCAGRがxxx%になると予測されます。アジア太平洋地域では、日本と韓国の成長率が、今後5年間でそれぞれxxx%とxxx%になると展望されます。

世界の主要な新型コロナウイルス感染症用抗体&血清検査器プレーヤーとして、Abbott Laboratories、 Access Bio、 Cellex、 Babson Diagnostics、 Beckman Coulter、 Roche、 Bio-Rad Laboratories、 bioMérieux、 DiaSorin、 Diazyme Laboratories、 Emory Medical Laboratories、 EUROIMMUN、 Healgen、 InBios International、 Luminex Corporation、 BioMedomics、 Megna Health、 Mount Sinai Hospital Clinical Laboratory、 Ortho-Clinicalなどをカバーしています。売上の面では、世界最大の2社が2021年に約xxx%市場シェアを占めています。

当レポートでは、製品タイプ、アプリケーション(用途)、主要メーカー、主要地域および国ごとの新型コロナウイルス感染症用抗体&血清検査器市場の包括的な概要、市場シェア、および成長機会を掲載します。

タイプ別のセグメンテーション:2017年~2022年までの内訳データと2028年まで予測データ
ハイスループットCMIA、イムノフロー、ELISA、ELFA、その他

アプリケーション(用途)別のセグメンテーション:2017年~2022年までの内訳データと2028年まで予測データ
病院、診療所、学術研究センター、その他

当レポートは次の地域と国の市場規模データを掲載します。
南北アメリカ(アメリカ、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東/アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

また、当レポートは市場の競争状況と主要メーカーの詳細な分析を掲載します。
Abbott Laboratories、 Access Bio、 Cellex、 Babson Diagnostics、 Beckman Coulter、 Roche、 Bio-Rad Laboratories、 bioMérieux、 DiaSorin、 Diazyme Laboratories、 Emory Medical Laboratories、 EUROIMMUN、 Healgen、 InBios International、 Luminex Corporation、 BioMedomics、 Megna Health、 Mount Sinai Hospital Clinical Laboratory、 Ortho-Clinical

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:新型コロナウイルス感染症用抗体&血清検査器の年間販売量2017-2028、地域別現状・将来分析
・新型コロナウイルス感染症用抗体&血清検査器のタイプ別セグメント:ハイスループットCMIA、イムノフロー、ELISA、ELFA、その他
・新型コロナウイルス感染症用抗体&血清検査器のタイプ別販売量:2017-2022年の販売量、売上、市場シェア、販売価格
・新型コロナウイルス感染症用抗体&血清検査器の用途別セグメント:病院、診療所、学術研究センター、その他
・新型コロナウイルス感染症用抗体&血清検査器の用途別販売量:2017-2022年の販売量、売上、市場シェア、販売価格

企業別世界の新型コロナウイルス感染症用抗体&血清検査器市場
・企業別のグローバル新型コロナウイルス感染症用抗体&血清検査器市場データ:2020-2022年の年間販売量、市場シェア
・企業別の新型コロナウイルス感染症用抗体&血清検査器の年間売上:2020-2022年の売上、市場シェア
・企業別の新型コロナウイルス感染症用抗体&血清検査器販売価格
・主要企業の新型コロナウイルス感染症用抗体&血清検査器生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

新型コロナウイルス感染症用抗体&血清検査器の地域別レビュー
・地域別の新型コロナウイルス感染症用抗体&血清検査器市場規模2017-2022:年間販売量、売上
・主要国別の新型コロナウイルス感染症用抗体&血清検査器市場規模2017-2022:年間販売量、売上
・南北アメリカの新型コロナウイルス感染症用抗体&血清検査器販売の成長
・アジア太平洋の新型コロナウイルス感染症用抗体&血清検査器販売の成長
・ヨーロッパの新型コロナウイルス感染症用抗体&血清検査器販売の成長
・中東・アフリカの新型コロナウイルス感染症用抗体&血清検査器販売の成長

南北アメリカ市場
・南北アメリカの国別の新型コロナウイルス感染症用抗体&血清検査器販売量、売上(2017-2022)
・南北アメリカの新型コロナウイルス感染症用抗体&血清検査器の種類別販売量
・南北アメリカの新型コロナウイルス感染症用抗体&血清検査器の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の新型コロナウイルス感染症用抗体&血清検査器販売量、売上(2017-2022)
・アジア太平洋の新型コロナウイルス感染症用抗体&血清検査器の種類別販売量
・アジア太平洋の新型コロナウイルス感染症用抗体&血清検査器の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の新型コロナウイルス感染症用抗体&血清検査器販売量、売上(2017-2022)
・ヨーロッパの新型コロナウイルス感染症用抗体&血清検査器の種類別販売量
・ヨーロッパの新型コロナウイルス感染症用抗体&血清検査器の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の新型コロナウイルス感染症用抗体&血清検査器販売量、売上(2017-2022)
・中東・アフリカの新型コロナウイルス感染症用抗体&血清検査器の種類別販売量
・中東・アフリカの新型コロナウイルス感染症用抗体&血清検査器の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・新型コロナウイルス感染症用抗体&血清検査器の製造コスト構造分析
・新型コロナウイルス感染症用抗体&血清検査器の製造プロセス分析
・新型コロナウイルス感染症用抗体&血清検査器の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・新型コロナウイルス感染症用抗体&血清検査器の主要なグローバル販売業者
・新型コロナウイルス感染症用抗体&血清検査器の主要なグローバル顧客

地域別の新型コロナウイルス感染症用抗体&血清検査器市場予測レビュー
・地域別の新型コロナウイルス感染症用抗体&血清検査器市場規模予測(2023-2028)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・新型コロナウイルス感染症用抗体&血清検査器のタイプ別市場規模予測
・新型コロナウイルス感染症用抗体&血清検査器の用途別市場規模予測

主要企業分析
Abbott Laboratories、 Access Bio、 Cellex、 Babson Diagnostics、 Beckman Coulter、 Roche、 Bio-Rad Laboratories、 bioMérieux、 DiaSorin、 Diazyme Laboratories、 Emory Medical Laboratories、 EUROIMMUN、 Healgen、 InBios International、 Luminex Corporation、 BioMedomics、 Megna Health、 Mount Sinai Hospital Clinical Laboratory、 Ortho-Clinical
・企業情報
・新型コロナウイルス感染症用抗体&血清検査器製品
・新型コロナウイルス感染症用抗体&血清検査器販売量、売上、価格、粗利益(2020-2022)
・主要ビジネス概要
・最新動向

調査結果および結論

As the global economy mends, the 2021 growth of COVID-19 Antibody and Serology Tests will have significant change from previous year. According to our (LP Information) latest study, the global COVID-19 Antibody and Serology Tests market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global COVID-19 Antibody and Serology Tests market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States COVID-19 Antibody and Serology Tests market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global COVID-19 Antibody and Serology Tests market, reaching US$ million by the year 2028. As for the Europe COVID-19 Antibody and Serology Tests landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main COVID-19 Antibody and Serology Tests players cover Abbott Laboratories, Access Bio, Cellex, and Babson Diagnostics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of COVID-19 Antibody and Serology Tests market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
High Throughput CMIA
Lateral Flow
ELISA
ELFA
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Clinics
Academic and Research Center
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Abbott Laboratories
Access Bio
Cellex
Babson Diagnostics
Beckman Coulter
Roche
Bio-Rad Laboratories
bioMérieux
DiaSorin
Diazyme Laboratories
Emory Medical Laboratories
EUROIMMUN
Healgen
InBios International
Luminex Corporation
BioMedomics
Megna Health
Mount Sinai Hospital Clinical Laboratory
Ortho-Clinical Diagnostics
Siemens Healthcare Diagnostics
Vibrant America Clinical Labs
Wadsworth Center
Dynamiker Biotechnology (Tianjin)
ADVAITE
Shanghai Xinchao Biology Technology
BGI
Wuhan Easy Diagnosis Biomedicine
Zhejiang Orient Gene Biotech

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global COVID-19 Antibody and Serology Tests Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for COVID-19 Antibody and Serology Tests by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for COVID-19 Antibody and Serology Tests by Country/Region, 2017, 2022 & 2028
2.2 COVID-19 Antibody and Serology Tests Segment by Type
2.2.1 High Throughput CMIA
2.2.2 Lateral Flow
2.2.3 ELISA
2.2.4 ELFA
2.2.5 Others
2.3 COVID-19 Antibody and Serology Tests Sales by Type
2.3.1 Global COVID-19 Antibody and Serology Tests Sales Market Share by Type (2017-2022)
2.3.2 Global COVID-19 Antibody and Serology Tests Revenue and Market Share by Type (2017-2022)
2.3.3 Global COVID-19 Antibody and Serology Tests Sale Price by Type (2017-2022)
2.4 COVID-19 Antibody and Serology Tests Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Academic and Research Center
2.4.4 Others
2.5 COVID-19 Antibody and Serology Tests Sales by Application
2.5.1 Global COVID-19 Antibody and Serology Tests Sale Market Share by Application (2017-2022)
2.5.2 Global COVID-19 Antibody and Serology Tests Revenue and Market Share by Application (2017-2022)
2.5.3 Global COVID-19 Antibody and Serology Tests Sale Price by Application (2017-2022)
3 Global COVID-19 Antibody and Serology Tests by Company
3.1 Global COVID-19 Antibody and Serology Tests Breakdown Data by Company
3.1.1 Global COVID-19 Antibody and Serology Tests Annual Sales by Company (2020-2022)
3.1.2 Global COVID-19 Antibody and Serology Tests Sales Market Share by Company (2020-2022)
3.2 Global COVID-19 Antibody and Serology Tests Annual Revenue by Company (2020-2022)
3.2.1 Global COVID-19 Antibody and Serology Tests Revenue by Company (2020-2022)
3.2.2 Global COVID-19 Antibody and Serology Tests Revenue Market Share by Company (2020-2022)
3.3 Global COVID-19 Antibody and Serology Tests Sale Price by Company
3.4 Key Manufacturers COVID-19 Antibody and Serology Tests Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers COVID-19 Antibody and Serology Tests Product Location Distribution
3.4.2 Players COVID-19 Antibody and Serology Tests Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for COVID-19 Antibody and Serology Tests by Geographic Region
4.1 World Historic COVID-19 Antibody and Serology Tests Market Size by Geographic Region (2017-2022)
4.1.1 Global COVID-19 Antibody and Serology Tests Annual Sales by Geographic Region (2017-2022)
4.1.2 Global COVID-19 Antibody and Serology Tests Annual Revenue by Geographic Region
4.2 World Historic COVID-19 Antibody and Serology Tests Market Size by Country/Region (2017-2022)
4.2.1 Global COVID-19 Antibody and Serology Tests Annual Sales by Country/Region (2017-2022)
4.2.2 Global COVID-19 Antibody and Serology Tests Annual Revenue by Country/Region
4.3 Americas COVID-19 Antibody and Serology Tests Sales Growth
4.4 APAC COVID-19 Antibody and Serology Tests Sales Growth
4.5 Europe COVID-19 Antibody and Serology Tests Sales Growth
4.6 Middle East & Africa COVID-19 Antibody and Serology Tests Sales Growth
5 Americas
5.1 Americas COVID-19 Antibody and Serology Tests Sales by Country
5.1.1 Americas COVID-19 Antibody and Serology Tests Sales by Country (2017-2022)
5.1.2 Americas COVID-19 Antibody and Serology Tests Revenue by Country (2017-2022)
5.2 Americas COVID-19 Antibody and Serology Tests Sales by Type
5.3 Americas COVID-19 Antibody and Serology Tests Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC COVID-19 Antibody and Serology Tests Sales by Region
6.1.1 APAC COVID-19 Antibody and Serology Tests Sales by Region (2017-2022)
6.1.2 APAC COVID-19 Antibody and Serology Tests Revenue by Region (2017-2022)
6.2 APAC COVID-19 Antibody and Serology Tests Sales by Type
6.3 APAC COVID-19 Antibody and Serology Tests Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe COVID-19 Antibody and Serology Tests by Country
7.1.1 Europe COVID-19 Antibody and Serology Tests Sales by Country (2017-2022)
7.1.2 Europe COVID-19 Antibody and Serology Tests Revenue by Country (2017-2022)
7.2 Europe COVID-19 Antibody and Serology Tests Sales by Type
7.3 Europe COVID-19 Antibody and Serology Tests Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa COVID-19 Antibody and Serology Tests by Country
8.1.1 Middle East & Africa COVID-19 Antibody and Serology Tests Sales by Country (2017-2022)
8.1.2 Middle East & Africa COVID-19 Antibody and Serology Tests Revenue by Country (2017-2022)
8.2 Middle East & Africa COVID-19 Antibody and Serology Tests Sales by Type
8.3 Middle East & Africa COVID-19 Antibody and Serology Tests Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of COVID-19 Antibody and Serology Tests
10.3 Manufacturing Process Analysis of COVID-19 Antibody and Serology Tests
10.4 Industry Chain Structure of COVID-19 Antibody and Serology Tests
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 COVID-19 Antibody and Serology Tests Distributors
11.3 COVID-19 Antibody and Serology Tests Customer
12 World Forecast Review for COVID-19 Antibody and Serology Tests by Geographic Region
12.1 Global COVID-19 Antibody and Serology Tests Market Size Forecast by Region
12.1.1 Global COVID-19 Antibody and Serology Tests Forecast by Region (2023-2028)
12.1.2 Global COVID-19 Antibody and Serology Tests Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global COVID-19 Antibody and Serology Tests Forecast by Type
12.7 Global COVID-19 Antibody and Serology Tests Forecast by Application
13 Key Players Analysis
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories COVID-19 Antibody and Serology Tests Product Offered
13.1.3 Abbott Laboratories COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 Access Bio
13.2.1 Access Bio Company Information
13.2.2 Access Bio COVID-19 Antibody and Serology Tests Product Offered
13.2.3 Access Bio COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Access Bio Main Business Overview
13.2.5 Access Bio Latest Developments
13.3 Cellex
13.3.1 Cellex Company Information
13.3.2 Cellex COVID-19 Antibody and Serology Tests Product Offered
13.3.3 Cellex COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Cellex Main Business Overview
13.3.5 Cellex Latest Developments
13.4 Babson Diagnostics
13.4.1 Babson Diagnostics Company Information
13.4.2 Babson Diagnostics COVID-19 Antibody and Serology Tests Product Offered
13.4.3 Babson Diagnostics COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Babson Diagnostics Main Business Overview
13.4.5 Babson Diagnostics Latest Developments
13.5 Beckman Coulter
13.5.1 Beckman Coulter Company Information
13.5.2 Beckman Coulter COVID-19 Antibody and Serology Tests Product Offered
13.5.3 Beckman Coulter COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Beckman Coulter Main Business Overview
13.5.5 Beckman Coulter Latest Developments
13.6 Roche
13.6.1 Roche Company Information
13.6.2 Roche COVID-19 Antibody and Serology Tests Product Offered
13.6.3 Roche COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Roche Main Business Overview
13.6.5 Roche Latest Developments
13.7 Bio-Rad Laboratories
13.7.1 Bio-Rad Laboratories Company Information
13.7.2 Bio-Rad Laboratories COVID-19 Antibody and Serology Tests Product Offered
13.7.3 Bio-Rad Laboratories COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Bio-Rad Laboratories Main Business Overview
13.7.5 Bio-Rad Laboratories Latest Developments
13.8 bioMérieux
13.8.1 bioMérieux Company Information
13.8.2 bioMérieux COVID-19 Antibody and Serology Tests Product Offered
13.8.3 bioMérieux COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 bioMérieux Main Business Overview
13.8.5 bioMérieux Latest Developments
13.9 DiaSorin
13.9.1 DiaSorin Company Information
13.9.2 DiaSorin COVID-19 Antibody and Serology Tests Product Offered
13.9.3 DiaSorin COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 DiaSorin Main Business Overview
13.9.5 DiaSorin Latest Developments
13.10 Diazyme Laboratories
13.10.1 Diazyme Laboratories Company Information
13.10.2 Diazyme Laboratories COVID-19 Antibody and Serology Tests Product Offered
13.10.3 Diazyme Laboratories COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Diazyme Laboratories Main Business Overview
13.10.5 Diazyme Laboratories Latest Developments
13.11 Emory Medical Laboratories
13.11.1 Emory Medical Laboratories Company Information
13.11.2 Emory Medical Laboratories COVID-19 Antibody and Serology Tests Product Offered
13.11.3 Emory Medical Laboratories COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Emory Medical Laboratories Main Business Overview
13.11.5 Emory Medical Laboratories Latest Developments
13.12 EUROIMMUN
13.12.1 EUROIMMUN Company Information
13.12.2 EUROIMMUN COVID-19 Antibody and Serology Tests Product Offered
13.12.3 EUROIMMUN COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 EUROIMMUN Main Business Overview
13.12.5 EUROIMMUN Latest Developments
13.13 Healgen
13.13.1 Healgen Company Information
13.13.2 Healgen COVID-19 Antibody and Serology Tests Product Offered
13.13.3 Healgen COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Healgen Main Business Overview
13.13.5 Healgen Latest Developments
13.14 InBios International
13.14.1 InBios International Company Information
13.14.2 InBios International COVID-19 Antibody and Serology Tests Product Offered
13.14.3 InBios International COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 InBios International Main Business Overview
13.14.5 InBios International Latest Developments
13.15 Luminex Corporation
13.15.1 Luminex Corporation Company Information
13.15.2 Luminex Corporation COVID-19 Antibody and Serology Tests Product Offered
13.15.3 Luminex Corporation COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Luminex Corporation Main Business Overview
13.15.5 Luminex Corporation Latest Developments
13.16 BioMedomics
13.16.1 BioMedomics Company Information
13.16.2 BioMedomics COVID-19 Antibody and Serology Tests Product Offered
13.16.3 BioMedomics COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 BioMedomics Main Business Overview
13.16.5 BioMedomics Latest Developments
13.17 Megna Health
13.17.1 Megna Health Company Information
13.17.2 Megna Health COVID-19 Antibody and Serology Tests Product Offered
13.17.3 Megna Health COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Megna Health Main Business Overview
13.17.5 Megna Health Latest Developments
13.18 Mount Sinai Hospital Clinical Laboratory
13.18.1 Mount Sinai Hospital Clinical Laboratory Company Information
13.18.2 Mount Sinai Hospital Clinical Laboratory COVID-19 Antibody and Serology Tests Product Offered
13.18.3 Mount Sinai Hospital Clinical Laboratory COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Mount Sinai Hospital Clinical Laboratory Main Business Overview
13.18.5 Mount Sinai Hospital Clinical Laboratory Latest Developments
13.19 Ortho-Clinical Diagnostics
13.19.1 Ortho-Clinical Diagnostics Company Information
13.19.2 Ortho-Clinical Diagnostics COVID-19 Antibody and Serology Tests Product Offered
13.19.3 Ortho-Clinical Diagnostics COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Ortho-Clinical Diagnostics Main Business Overview
13.19.5 Ortho-Clinical Diagnostics Latest Developments
13.20 Siemens Healthcare Diagnostics
13.20.1 Siemens Healthcare Diagnostics Company Information
13.20.2 Siemens Healthcare Diagnostics COVID-19 Antibody and Serology Tests Product Offered
13.20.3 Siemens Healthcare Diagnostics COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Siemens Healthcare Diagnostics Main Business Overview
13.20.5 Siemens Healthcare Diagnostics Latest Developments
13.21 Vibrant America Clinical Labs
13.21.1 Vibrant America Clinical Labs Company Information
13.21.2 Vibrant America Clinical Labs COVID-19 Antibody and Serology Tests Product Offered
13.21.3 Vibrant America Clinical Labs COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Vibrant America Clinical Labs Main Business Overview
13.21.5 Vibrant America Clinical Labs Latest Developments
13.22 Wadsworth Center
13.22.1 Wadsworth Center Company Information
13.22.2 Wadsworth Center COVID-19 Antibody and Serology Tests Product Offered
13.22.3 Wadsworth Center COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 Wadsworth Center Main Business Overview
13.22.5 Wadsworth Center Latest Developments
13.23 Dynamiker Biotechnology (Tianjin)
13.23.1 Dynamiker Biotechnology (Tianjin) Company Information
13.23.2 Dynamiker Biotechnology (Tianjin) COVID-19 Antibody and Serology Tests Product Offered
13.23.3 Dynamiker Biotechnology (Tianjin) COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.23.4 Dynamiker Biotechnology (Tianjin) Main Business Overview
13.23.5 Dynamiker Biotechnology (Tianjin) Latest Developments
13.24 ADVAITE
13.24.1 ADVAITE Company Information
13.24.2 ADVAITE COVID-19 Antibody and Serology Tests Product Offered
13.24.3 ADVAITE COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.24.4 ADVAITE Main Business Overview
13.24.5 ADVAITE Latest Developments
13.25 Shanghai Xinchao Biology Technology
13.25.1 Shanghai Xinchao Biology Technology Company Information
13.25.2 Shanghai Xinchao Biology Technology COVID-19 Antibody and Serology Tests Product Offered
13.25.3 Shanghai Xinchao Biology Technology COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.25.4 Shanghai Xinchao Biology Technology Main Business Overview
13.25.5 Shanghai Xinchao Biology Technology Latest Developments
13.26 BGI
13.26.1 BGI Company Information
13.26.2 BGI COVID-19 Antibody and Serology Tests Product Offered
13.26.3 BGI COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.26.4 BGI Main Business Overview
13.26.5 BGI Latest Developments
13.27 Wuhan Easy Diagnosis Biomedicine
13.27.1 Wuhan Easy Diagnosis Biomedicine Company Information
13.27.2 Wuhan Easy Diagnosis Biomedicine COVID-19 Antibody and Serology Tests Product Offered
13.27.3 Wuhan Easy Diagnosis Biomedicine COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.27.4 Wuhan Easy Diagnosis Biomedicine Main Business Overview
13.27.5 Wuhan Easy Diagnosis Biomedicine Latest Developments
13.28 Zhejiang Orient Gene Biotech
13.28.1 Zhejiang Orient Gene Biotech Company Information
13.28.2 Zhejiang Orient Gene Biotech COVID-19 Antibody and Serology Tests Product Offered
13.28.3 Zhejiang Orient Gene Biotech COVID-19 Antibody and Serology Tests Sales, Revenue, Price and Gross Margin (2020-2022)
13.28.4 Zhejiang Orient Gene Biotech Main Business Overview
13.28.5 Zhejiang Orient Gene Biotech Latest Developments
14 Research Findings and Conclusion



★調査レポート[世界の新型コロナウイルス感染症用抗体&血清検査器市場予測 2022年-2028年] (コード:LPI22SM17186)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の新型コロナウイルス感染症用抗体&血清検査器市場予測 2022年-2028年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆